Jindike released its 2026 interim report, with net profit attributable to the parent company at negative 51.07 million yuan, a loss expansion of 11.42 million yuan compared with the same period last year. The company's total operating revenue was 910,900 yuan, down 74.15 percent year-on-year. Net cash flow from operating activities was negative 35.31 million yuan, an increase of 50.18 million yuan over the same period last year, achieving two consecutive years of growth. The company's latest asset-liability ratio was 20.66 percent, gross margin was negative 279.01 percent, ROE was negative 4.87 percent, and diluted earnings per share was negative 0.41 yuan.
Jiangsu GDK Biotechnology Co LtdNet loss widened to 51.07 million yuan with revenue down 74.15% and negative gross margin.